Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Colchicine for PVR Prevention in RRD
NCT00370201Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2004
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3 trial of colchicine in Proliferative Vitreoretinopathy (PVR), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: proliferative vitreoretinopathy and retinal reattachment rate. Status: unknown.
02
Drugs
colchicine
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT00370201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370201.